Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals

Journal of Clinical Microbiology

Volumn 39, Issue 5, 2001, Pages 1859-1864

  Schumacher, A ^a   Lerkerod A B ^a   Seljeflot, I ^a   Sommervoll, L ^a   Holme, I ^a   Otterstad, J E ^a   Arnesen, H ^a  

^a Vestfold Central Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE;

ADULT; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; IMMUNOASSAY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; TECHNIQUE;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0035024963     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.5.1859-1864.2001     Document Type: Article

References (37)

1. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia; comparative efficacy and safety of chlarithromycin vs. erythromycin ethylsuccinate
2. Occurence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen
3. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and trancient cerebral ischaemia: The West Birmingham Stroke Project
4. Prävalenz von Chlamydien-Antikörpern bei Patienten mit koronarer Herzerkrankung
5. The association of Chlamydia pneumoniae infection and reactive airway disease in children
6. Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci
7. A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart
8. Chlamydia pneumoniae, strain TWAR and atherosclerosis
9. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
10. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease
11. Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp
12. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis
13. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem
14. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island - Evidence of serologic cross-reactivity
15. Chlamydial antibodies in an elderly Finnish population
16. Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions
17. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerotic by immunocytochemical stain
18. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
19. Antibody response to Chlamydia pneumoniae infection in children with respiratory illness
20. Endovascular presence of viable Chlamydia pneumonae is a common phenomenon in coronary artery disease
21. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up
22. Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart disease
23. Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to Chlamydia pneumoniae and Chlamydia psittaci on the sensitivity and the specificity of Chlamydia trachomatis serology tests
24. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of atherosclerotic disease
25. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections
26. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
27. Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae
28. Baseline IgG antibody titers to Chlamydia pneumoniae. Helicobacter pylori, herpes simplex virus and cytomegalovirus and the risk for cardiovascular disease in women
29. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
30. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
31. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
32. Chlamydia pneumoniae and atherosclerotic risk in populations: The role of seroepidemiology
33. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study
34. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease
35. Comparison of Chlamydia pneumoniae isolates by Western blot (immunoblot) analysis and DNA sequencing of the omp2 gene
36. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy